Thank you. And our next question comes from Mark Astrachan of Stifel. Your line is now open.
Mark Astrachan - Stifel, Nicolaus & Co., Inc.: Yeah. Thanks and good morning. So, just wanted to continue on that last line of thinking. So, if you take the consolidated results that you provided in the second 8-K this morning, before talking about the incremental depreciation and higher interest expense, the base is, call it, $0.95, take into account the $50 million of dis-synergies, to $0.90, is that roughly what we should be thinking about as the earnings base before the decline in 2017?
Patrice de Talhouët - Coty, Inc.: No, we're not going to go into any guidance on that, but I think you should really come back to the previous statement I made, which are that you should factor in to the way you should look at it the additional depreciation. The interest line, the tax line and the $50 million dis-synergies based on what we have seen in fiscal 2016.
Mark Astrachan - Stifel, Nicolaus & Co., Inc.: Okay.
Patrice de Talhouët - Coty, Inc.: I think that will give you the answer to your question.
Mark Astrachan - Stifel, Nicolaus & Co., Inc.: All right. And then switching back to the sales growth numbers. So, could you talk about how both the legacy business and the Procter brands are doing on an expectation basis in terms of that real improvement, and I guess in particular if you look at the results that you disclosed in that same 8-K, the Procter brands looked like they were down marginally compared to the Coty business. So is it fair to think that the Procter business is performing better on whole than the Coty business? And then just going back to the previous commentary, how then should we think about where the greatest relative improvement is going to come from on a go-forward basis, meaning through the year to that real improvement?